- Home
- CNM vs EXEL Comparison
CNM vs EXEL Comparison
Compare CNM & EXEL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CNM
- EXEL
- Stock Information
- Founded
- CNM 1996
- EXEL 1994
- Country
- CNM United States
- EXEL United States
- Employees
- CNM N/A
- EXEL N/A
- Industry
- CNM Durable Goods
- EXEL Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- CNM Consumer Discretionary
- EXEL Health Care
- Exchange
- CNM Nasdaq
- EXEL Nasdaq
- Market Cap
- CNM 9.6B
- EXEL 9.8B
- IPO Year
- CNM 2021
- EXEL 2000
- Fundamental
- Price
- CNM $54.80
- EXEL $43.04
- Analyst Decision
- CNM Buy
- EXEL Buy
- Analyst Count
- CNM 11
- EXEL 18
- Target Price
- CNM $57.91
- EXEL $38.76
- AVG Volume (30 Days)
- CNM 1.9M
- EXEL 3.9M
- Earning Date
- CNM 06-10-2025
- EXEL 05-13-2025
- Dividend Yield
- CNM N/A
- EXEL N/A
- EPS Growth
- CNM N/A
- EXEL 237.58
- EPS
- CNM 2.13
- EXEL 2.20
- Revenue
- CNM $7,441,000,000.00
- EXEL $2,298,922,000.00
- Revenue This Year
- CNM $5.39
- EXEL $10.39
- Revenue Next Year
- CNM $4.42
- EXEL $10.74
- P/E Ratio
- CNM $25.74
- EXEL $19.53
- Revenue Growth
- CNM 11.03
- EXEL 24.49
- 52 Week Low
- CNM $37.22
- EXEL $20.40
- 52 Week High
- CNM $58.29
- EXEL $48.85
- Technical
- Relative Strength Index (RSI)
- CNM 60.30
- EXEL 59.93
- Support Level
- CNM $53.52
- EXEL $42.21
- Resistance Level
- CNM $55.08
- EXEL $43.75
- Average True Range (ATR)
- CNM 1.25
- EXEL 1.60
- MACD
- CNM 0.07
- EXEL -0.09
- Stochastic Oscillator
- CNM 93.24
- EXEL 53.96
About CNM Core & Main Inc.
Core & Main Inc is a specialty distributor focusing on water, wastewater, storm drainage, and fire protection products and services. Catering to municipalities, private water companies, and contractors, it serves municipal, non-residential, and residential markets nationwide. Its diverse product line includes pipes, valves, fittings, storm drainage products, fire protection products, and meter products. Revenue is principally generated from pipes, valves, and fittings. The company operates across three construction sectors: municipal, non-residential, and residential, contributing to reliable infrastructure development nationwide.
About EXEL Exelixis Inc.
Exelixis Inc is a biopharmaceutical firm that discovers, develops, and commercializes treatments for cancer. Its molecule, cabozantinib, is indicated for the treatment of patients with metastatic medullary thyroid cancer under the name Cometriq and for the treatment of kidney and liver cancer under the name Cabometyx. Exelixis and its partner Roche have also brought Cotellic to market for the treatment of melanoma.